Industry: Service & Software
Published Date: 2024-11-15
Pages: 130 Pages
Report ld: 3379255
Request Sample
Customized Report
Postbiotics CDMO Service Market Size(US$)

CAGR 2024-2030
9.3%
Market Size,2030
USD 168
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Postbiotics CDMO Service market is projected to grow from US$ 99 million in 2024 to US$ 168 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.3% during the forecast period.
Postbiotics are inactivated microorganisms and/or bacterial components with a clear genetic background that are beneficial to the health of the host, including or excluding products of their metabolites; chemically synthesized components and viruses/bacteriophages and their products are excluded. Postbiotic products are added with postbiotic ingredients and are widely used in different fields (feed, food health, personal care, pet nutrition, etc.).CDMOs (Contract Development and Manufacturing Organizations) provide professional R&D and production services to other companies to help them bring postbiotic products to market. These organizations usually have extensive R&D experience and production capabilities to meet the needs of different customers.
The US & Canada market for Postbiotics CDMO Service is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Postbiotics CDMO Service is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Postbiotics CDMO Service is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Postbiotics CDMO Service include ILDONG Bioscience Co., Ltd., Bioprox Healthcare, Exden, JuneYao Group (BioGrowing), dsm-firmenich (Adare Pharma Solutions), Sirio Pharma, Sacco System, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Postbiotics CDMO Service market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Postbiotics CDMO Service, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Postbiotics CDMO Service, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Postbiotics CDMO Service revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Postbiotics CDMO Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Postbiotics CDMO Service revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including ILDONG Bioscience Co., Ltd., Bioprox Healthcare, Exden, JuneYao Group (BioGrowing), dsm-firmenich (Adare Pharma Solutions), Sirio Pharma, Sacco System, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Postbiotics CDMO Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Postbiotics CDMO Service companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Postbiotics CDMO Service revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Postbiotics CDMO Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Dosage Forms (Capsules And Tablets)
1.2.3 Powders and Granules
1.2.4 Liquid Preparations
1.3 Market by Application
1.3.1 Global Postbiotics CDMO Service Market Share by Application: 2019 VS 2023 VS 2030
1.3.2 Medicines and Health Products
1.3.3 Food
1.3.4 Pet Food
1.3.5 Cosmetics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Postbiotics CDMO Service Market Perspective (2019-2030)
2.2 Global Postbiotics CDMO Service Growth Trends by Region
2.2.1 Global Postbiotics CDMO Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Postbiotics CDMO Service Historic Market Size by Region (2019-2024)
2.2.3 Postbiotics CDMO Service Forecasted Market Size by Region (2025-2030)
2.3 Postbiotics CDMO Service Market Dynamics
2.3.1 Postbiotics CDMO Service Industry Trends
2.3.2 Postbiotics CDMO Service Market Drivers
2.3.3 Postbiotics CDMO Service Market Challenges
2.3.4 Postbiotics CDMO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Postbiotics CDMO Service by Players
3.1.1 Global Postbiotics CDMO Service Revenue by Players (2019-2024)
3.1.2 Global Postbiotics CDMO Service Revenue Market Share by Players (2019-2024)
3.2 Global Postbiotics CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Postbiotics CDMO Service, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Postbiotics CDMO Service Market Concentration Ratio
3.4.1 Global Postbiotics CDMO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Postbiotics CDMO Service Revenue in 2023
3.5 Global Key Players of Postbiotics CDMO Service Head office and Area Served
3.6 Global Key Players of Postbiotics CDMO Service, Product and Application
3.7 Global Key Players of Postbiotics CDMO Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Postbiotics CDMO Service Breakdown Data by Type
4.1 Global Postbiotics CDMO Service Historic Market Size by Type (2019-2024)
4.2 Global Postbiotics CDMO Service Forecasted Market Size by Type (2025-2030)
5 Postbiotics CDMO Service Breakdown Data by Application
5.1 Global Postbiotics CDMO Service Historic Market Size by Application (2019-2024)
5.2 Global Postbiotics CDMO Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Postbiotics CDMO Service Market Size (2019-2030)
6.2 North America Postbiotics CDMO Service Market Size by Type
6.2.1 North America Postbiotics CDMO Service Market Size by Type (2019-2024)
6.2.2 North America Postbiotics CDMO Service Market Size by Type (2025-2030)
6.2.3 North America Postbiotics CDMO Service Market Share by Type (2019-2030)
6.3 North America Postbiotics CDMO Service Market Size by Application
6.3.1 North America Postbiotics CDMO Service Market Size by Application (2019-2024)
6.3.2 North America Postbiotics CDMO Service Market Size by Application (2025-2030)
6.3.3 North America Postbiotics CDMO Service Market Share by Application (2019-2030)
6.4 North America Postbiotics CDMO Service Market Size by Country
6.4.1 North America Postbiotics CDMO Service Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Postbiotics CDMO Service Market Size by Country (2019-2024)
6.4.3 North America Postbiotics CDMO Service Market Share by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Postbiotics CDMO Service Market Size (2019-2030)
7.2 Europe Postbiotics CDMO Service Market Size by Type
7.2.1 Europe Postbiotics CDMO Service Market Size by Type (2019-2024)
7.2.2 Europe Postbiotics CDMO Service Market Size by Type (2025-2030)
7.2.3 Europe Postbiotics CDMO Service Market Share by Type (2019-2030)
7.3 Europe Postbiotics CDMO Service Market Size by Application
7.3.1 Europe Postbiotics CDMO Service Market Size by Application (2019-2024)
7.3.2 Europe Postbiotics CDMO Service Market Size by Application (2025-2030)
7.3.3 Europe Postbiotics CDMO Service Market Share by Application (2019-2030)
7.4 Europe Postbiotics CDMO Service Market Size by Country
7.4.1 Europe Postbiotics CDMO Service Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Postbiotics CDMO Service Market Size by Country (2019-2024)
7.4.3 Europe Postbiotics CDMO Service Market Size by Country (2025-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
7.4.9 Nordic Countries
8 China
8.1 China Postbiotics CDMO Service Market Size (2019-2030)
8.2 China Postbiotics CDMO Service Market Size by Type
8.2.1 China Postbiotics CDMO Service Market Size by Type (2019-2024)
8.2.2 China Postbiotics CDMO Service Market Size by Type (2025-2030)
8.2.3 China Postbiotics CDMO Service Market Share by Type (2019-2030)
8.3 China Postbiotics CDMO Service Market Size by Application
8.3.1 China Postbiotics CDMO Service Market Size by Application (2019-2024)
8.3.2 China Postbiotics CDMO Service Market Size by Application (2025-2030)
8.3.3 China Postbiotics CDMO Service Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Postbiotics CDMO Service Market Size (2019-2030)
9.2 Asia Postbiotics CDMO Service Market Size by Type
9.2.1 Asia Postbiotics CDMO Service Market Size by Type (2019-2024)
9.2.2 Asia Postbiotics CDMO Service Market Size by Type (2025-2030)
9.2.3 Asia Postbiotics CDMO Service Market Share by Type (2019-2030)
9.3 Asia Postbiotics CDMO Service Market Size by Application
9.3.1 Asia Postbiotics CDMO Service Market Size by Application (2019-2024)
9.3.2 Asia Postbiotics CDMO Service Market Size by Application (2025-2030)
9.3.3 Asia Postbiotics CDMO Service Market Share by Application (2019-2030)
9.4 Asia Postbiotics CDMO Service Market Size by Region
9.4.1 Asia Postbiotics CDMO Service Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Postbiotics CDMO Service Market Size by Region (2019-2024)
9.4.3 Asia Postbiotics CDMO Service Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Postbiotics CDMO Service Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Postbiotics CDMO Service Market Size by Type
10.2.1 Middle East, Africa, and Latin America Postbiotics CDMO Service Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Postbiotics CDMO Service Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Postbiotics CDMO Service Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Postbiotics CDMO Service Market Size by Application
10.3.1 Middle East, Africa, and Latin America Postbiotics CDMO Service Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Postbiotics CDMO Service Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Postbiotics CDMO Service Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Postbiotics CDMO Service Market Size by Country
10.4.1 Middle East, Africa, and Latin America Postbiotics CDMO Service Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Postbiotics CDMO Service Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Postbiotics CDMO Service Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 ILDONG Bioscience Co., Ltd.
11.1.1 ILDONG Bioscience Co., Ltd. Company Details
11.1.2 ILDONG Bioscience Co., Ltd. Business Overview
11.1.3 ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Introduction
11.1.4 ILDONG Bioscience Co., Ltd. Revenue in Postbiotics CDMO Service Business (2019-2024)
11.1.5 ILDONG Bioscience Co., Ltd. Recent Development
11.2 Bioprox Healthcare
11.2.1 Bioprox Healthcare Company Details
11.2.2 Bioprox Healthcare Business Overview
11.2.3 Bioprox Healthcare Postbiotics CDMO Service Introduction
11.2.4 Bioprox Healthcare Revenue in Postbiotics CDMO Service Business (2019-2024)
11.2.5 Bioprox Healthcare Recent Development
11.3 Exden
11.3.1 Exden Company Details
11.3.2 Exden Business Overview
11.3.3 Exden Postbiotics CDMO Service Introduction
11.3.4 Exden Revenue in Postbiotics CDMO Service Business (2019-2024)
11.3.5 Exden Recent Development
11.4 JuneYao Group (BioGrowing)
11.4.1 JuneYao Group (BioGrowing) Company Details
11.4.2 JuneYao Group (BioGrowing) Business Overview
11.4.3 JuneYao Group (BioGrowing) Postbiotics CDMO Service Introduction
11.4.4 JuneYao Group (BioGrowing) Revenue in Postbiotics CDMO Service Business (2019-2024)
11.4.5 JuneYao Group (BioGrowing) Recent Development
11.5 dsm-firmenich (Adare Pharma Solutions)
11.5.1 dsm-firmenich (Adare Pharma Solutions) Company Details
11.5.2 dsm-firmenich (Adare Pharma Solutions) Business Overview
11.5.3 dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Introduction
11.5.4 dsm-firmenich (Adare Pharma Solutions) Revenue in Postbiotics CDMO Service Business (2019-2024)
11.5.5 dsm-firmenich (Adare Pharma Solutions) Recent Development
11.6 Sirio Pharma
11.6.1 Sirio Pharma Company Details
11.6.2 Sirio Pharma Business Overview
11.6.3 Sirio Pharma Postbiotics CDMO Service Introduction
11.6.4 Sirio Pharma Revenue in Postbiotics CDMO Service Business (2019-2024)
11.6.5 Sirio Pharma Recent Development
11.7 Sacco System
11.7.1 Sacco System Company Details
11.7.2 Sacco System Business Overview
11.7.3 Sacco System Postbiotics CDMO Service Introduction
11.7.4 Sacco System Revenue in Postbiotics CDMO Service Business (2019-2024)
11.7.5 Sacco System Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Postbiotics CDMO Service market is projected to grow from US$ 107 million in 2025 to US$ 198 million by 2032, at a CAGR of 9.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-25
Pages: 118
USD 4900.00
(Single User License)
The global Postbiotics CDMO Service market size was US$ 107 million in 2025 and is forecast to reach a readjusted size of US$ 198 million by 2032 with a CAGR of 9.3% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 76
USD 4250.00
(Single User License)
The global Postbiotics CDMO Service market was valued at US$ 107 million in 2025 and is anticipated to reach US$ 198 million by 2032, at a CAGR of 9.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 110
USD 2900.00
(Single User License)
The global market for Postbiotics CDMO Service was estimated to be worth US$ 107 million in 2025 and is projected to reach US$ 198 million, growing at a CAGR of 9.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 94
USD 3950.00
(Single User License)
The global Postbiotics CDMO Service market size was US$ 99 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 79
USD 4250.00
(Single User License)
The global Postbiotics CDMO Service market is projected to grow from US$ 99 million in 2024 to US$ 182 million by 2031, at a CAGR of 9.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-01
Pages: 123
USD 4900.00
(Single User License)
The global market for Postbiotics CDMO Service was estimated to be worth US$ 99 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 89
USD 3950.00
(Single User License)
The global market for Postbiotics CDMO Service was valued at US$ 99 million in the year 2024 and is projected to reach a revised size of US$ 182 million by 2031, growing at a CAGR of 9.3% during the forecast period.
Published Date: 2025-03-12
Pages: 77
USD 2900.00
(Single User License)
The global Postbiotics CDMO Service revenue was US$ 88.7 million in 2023 and is forecast to a readjusted size of US$ 168 million by 2030 with a CAGR of 9.3% during the review period (2024-2030).
Published Date: 2024-11-15
Pages: 98
USD 4350.00
(Single User License)
The global market for Postbiotics CDMO Service was estimated to be worth US$ 88.7 million in 2023 and is forecast to a readjusted size of US$ 168 million by 2030 with a CAGR of 9.3% during the forecast period 2024-2030.
Published Date: 2024-11-15
Pages: 99
USD 3950.00
(Single User License)
The global Postbiotics CDMO Service market is projected to grow from US$ 107 million in 2025 to US$ 198 million by 2032, at a CAGR of 9.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-25
Pages: 118
The global Postbiotics CDMO Service market size was US$ 107 million in 2025 and is forecast to reach a readjusted size of US$ 198 million by 2032 with a CAGR of 9.3% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 76
The global Postbiotics CDMO Service market was valued at US$ 107 million in 2025 and is anticipated to reach US$ 198 million by 2032, at a CAGR of 9.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 110
The global market for Postbiotics CDMO Service was estimated to be worth US$ 107 million in 2025 and is projected to reach US$ 198 million, growing at a CAGR of 9.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 94
The global Postbiotics CDMO Service market size was US$ 99 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 79
The global Postbiotics CDMO Service market is projected to grow from US$ 99 million in 2024 to US$ 182 million by 2031, at a CAGR of 9.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-01
Pages: 123
The global market for Postbiotics CDMO Service was estimated to be worth US$ 99 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 89
The global market for Postbiotics CDMO Service was valued at US$ 99 million in the year 2024 and is projected to reach a revised size of US$ 182 million by 2031, growing at a CAGR of 9.3% during the forecast period.
Published: 2025-03-12
Pages: 77
The global Postbiotics CDMO Service revenue was US$ 88.7 million in 2023 and is forecast to a readjusted size of US$ 168 million by 2030 with a CAGR of 9.3% during the review period (2024-2030).
Published: 2024-11-15
Pages: 98
The global market for Postbiotics CDMO Service was estimated to be worth US$ 88.7 million in 2023 and is forecast to a readjusted size of US$ 168 million by 2030 with a CAGR of 9.3% during the forecast period 2024-2030.
Published: 2024-11-15
Pages: 99
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now